Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lemuteporfin PDT for BPH
NCT00116571Phase 2Terminated
- Sponsor
- QLT Inc.
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of lemuteporfin in benign prostatic hyperplasia (BPH), sponsored by QLT Inc.. Started May 2005; status: terminated.
02
Drugs
lemuteporfin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00116571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00116571.